1. Introduction
As one of the major logistical drivers, transportation has a large impact on both responsiveness and efficiency of the supply chain [
1]. By ferrying goods from locations where they are sourced to locations where they are demanded, transportation provides the essential service of linking the whole supply chain from suppliers to customers [
2].
In today’s constantly changing environment, knowing how to successfully navigate these changes and make the appropriate and effective transportation decisions to properly make the products arrive safe to customers at right time, right place, and right cost is a must [
3]. With that in mind, transportation decisions in a supply chain can be characterized as strategic, planning, or operational, depending on the time period during which they apply [
1]. The strategic decisions have a long-term impact lasting several years. Planning decisions cover a period of a few months to a year and include decisions such as production plans, subcontracting, and promotions over that period. Operational decisions span from minutes to days and include sequencing production and filling specific orders. In this paper, we are interested in the strategic decisions as long-term decisions that focus on the overall supply-chain transportation system.
Many authors [
4,
5,
6] claim that continuous improvement and enhancement of transportation systems is required to satisfy increasing expectations of customers. In order to reach ever-increasing expectations, a solid and successful transportation decision-making process based on appropriate techniques and methods is highly desirable [
7,
8].
According to the literature [
5,
9], some of the main components that influence and facilitate the transportation decision-making process are as presented in
Figure 1.
The stakeholders are defined as any individual or group of individuals that can influence or are influenced by the decisions to be made [
10]. Stakeholder engagement is considered to be the process of involving stakeholders’ concerns, needs and values in the decision-making process, in order to achieve more informed, transparent and successful decisions [
5].
It has only been in more recent years that the stakeholders have become more engaged in making the appropriate transportation decisions and invited to give their ideas and express their needs and concerns [
15]. The awareness of including the stakeholders in the transportation decision-making process is a consequence of the failure of many projects because of lack of consensus building [
3]. Several researchers have pointed the importance of involving the stakeholders in the decision-making processes regarding different fields. In the transportation sector, Bickerstaff et al. [
16] noted that stakeholder participation should be fitted into all stages of the transportation strategy making process. Also, Erkul et al. [
17] discussed the benefits of involving the stakeholders and taking their views into consideration in transportation projects. In addition, Sussman et al. [
18] highlighted the importance of stakeholder participation in all the phases of the transportation strategic process. Furthermore, Haial et al. [
19] highlighted the importance of involving the concerns of different stakeholders in making the appropriate transportation decisions. Therefore, there has been a movement toward the development of transportation strategies in a more participative way.
Barriers: A successful transportation process management recognizes the potential barriers that may restrict the scope of the project or hinder project completion. According to Kelly et al. [
9], there are two broad categories of barriers that can be grouped for transportation. These include:
- (i)
Contextual barriers which include the financial, legal, and institutional barriers.
- -
Financial barriers: These are the barriers relating to the funding of a project.
- -
Legal barriers: These concern the legal regulation and requirements that inhibit the implementation of decisions to be made.
- -
Institutional barriers: These concern the rules and norms that stakeholders use to organize all forms of repetitive and structured interaction between them.
- (ii)
Process barriers which can occur at any stage of the process, including:
- -
Management barriers: These include any barriers relating to management of the decision-making process.
- -
Communication barriers: These concern the problems associated with achieving consensus between stakeholders on possible courses of actions.
Therefore, transportation decision making is considered as a highly complex process, requiring the participation of multiple concerned stakeholders with different interests, expectations, and varying perceptions [
2].
Several research works can be found in the literature that cover the topic of designing a transportation decision-making process. They are generally carried out to provide high-quality transportation decisions. Cascetta et al. [
5] proposed a transportation decision-making process based on three parallel and intertwined processes: a cognitive rational approach to organizing the decision-making process, a five-level of stakeholder-engagement process, and a revised role of quantitative methods developed over the decades for the design and evaluation of transportation projects. In the proposed model, the decisions are still cognitive/rational, i.e., they are based on the comparison of alternative courses of action, with regard to their expected effects and objectives. Furthermore, decisions are made by exploring a limited number of alternatives until reaching a solution that satisfies decision makers and the majority of stakeholders.
In other work, Le Pira et al. [
14] proposed a participatory transportation decision-making process that effectively includes the stakeholders’ opinions into the final decision. This process includes three main actors: planners and experts in charge of analyzing and modeling the transportation system by defining the plan structure for the final technical evaluations; stakeholders and citizens that are involved in all the planning phases for the definition of objectives, evaluation criteria, and alternatives; and decision makers in charge of the final decision supported by a performance-based ranking and a consensus-based ranking of plan alternatives.
Furthermore, Macharis et al. [
11] proposed a framework for the evaluation of transportation-related strategic decisions. The proposed framework consists of seven steps. The first step concerns the definition of the problem and the identification of the alternatives. Next, the various relevant stakeholders, as well as their key objectives, are identified. Thirdly, these objectives are translated into criteria and then given a relative importance. Fourthly, for each criterion, one or more indicators are constructed. The fifth step concerns the evaluation of each alternative contribution to the objectives of all stakeholders. Next, the sixth step gives a ranking of the various alternatives and gives the strong and weak points of the proposed alternatives. The last step of the framework includes the implementation of the chosen alternative. Also, reference [
6] proposed an agent-based model to support stakeholder involvement in deciding on the specific transportation policy.
In addition, reference [
20] proposed a modeling approach to support stakeholder involvement in urban-freight-transportation policy making. The proposed approach consists of an integration of discrete choice models (DCM) with agent-based models (ABM) to account for stakeholders’ opinions in the policy-making process, while mimicking their interactions to find a shared policy solution. In addition, Ignaccolo et al. [
21] presented a procedure for structuring a transportation decision-making problem while engaging the main stakeholders.
The analysis of these different transportation decision-making processes has shown the existence of many points of similarity. All of these processes involve a similar number of steps from the identification of the problem to be addressed, through the generation and assessment of alternatives to the implementation of the chosen alternatives and the monitoring of their impacts. Considering stakeholder participation and interaction in the process, all the previously described models have shown a vital interest in involving the stakeholders in all the phases of the process because of its benefits in making successful decisions. They considered that interaction is fundamental to the success of the decision-making process, because it allows one to increase the degree of consensus of the collective decision.
However, we have noticed that these studies do not deal with determining decisions regarding the transportation in a supply chain. We therefore determine a lack in establishing a decision-making process that helps in deciding on strategic transportation decisions in a supply chain.
Moreover, the transportation of pharmaceutical products, in particular, represents one of the most complicated operations in the pharmaceutical supply chain because of the sensitive nature and the specific characteristics of pharmaceuticals that require a high degree of attention during transportation [
22]. Improper transportation of pharmaceuticals not only affects customer satisfaction and supply-chain profit but could also present a real threat to public health and safety [
22]. Thus, making the appropriate pharmaceutical transportation decisions is a complex and challenging task. Several research studies have been conducted concerning the transportation of pharmaceutical products. Reference [
23] proposed a risk-assessment framework to select shipping lanes for pharmaceutical products. Kumar and Jha [
24] proposed a new application of principles of supply-chain management to the pharmaceutical-goods transportation practices in order to make quality products arrive to customers in a timely manner across the globe. Moreover, the analysis of the literature has shown that the majority of the studies used mathematical modeling to deal with transportation problems. For example, Goodarzian et al. [
25] proposed a mathematical programming with the objectives of minimizing the total costs and the delivery time of pharmaceutical products and of maximizing the reliability of the transportation system. In addition, Izadi and Mohammad Kimiagari [
26] proposed a mathematical model to design a distribution network under demand uncertainty for a pharmaceutical distribution companies in Iran. Therefore, we have noticed a gap in existing literature related to the design of transportation systems, while using technical methods other than mathematical modeling like the multicriteria decision-making methods.
In this paper, we are interested in presenting a participatory framework for deciding on the appropriate transportation strategy for a pharmaceutical supply chain while involving the interested stakeholders.
The rest of this paper is organized as follows: The suggested framework is presented in
Section 2.
Section 3 consists of a discussion regarding the key components of the proposed transportation strategy decision-making process. An illustration of the proposed framework in designing the appropriate transportation strategy for the Moroccan public pharmaceutical supply chain is presented in
Section 4. Finally, the results are discussed in
Section 5.
2. Suggested Framework for Designing Appropriate Transportation Strategy for a Supply Chain
Developing a successful supply-chain transportation strategy involves decision making regarding several components. Choosing the appropriate transportation mode, designing the transportation network, and deciding which part of the transportation process will be outsourced and which one will be insourced are the major decisions that must be made, while involving the relevant stakeholders and taking into account the specificities of products to be transported, in order to design an effective transportation strategy.
Based on the literature review, we proposed a transportation strategy decision-making process that effectively involves the stakeholders in all the phases of the process in order to help the decision makers in making the appropriate and the most shared decisions.
Figure 2 schematizes the proposed framework. Defining the transportation strategy decision-making context and the objectives that must be achieved is the first step of the framework. The second step consists of analyzing the actual transportation strategy regarding its three components: transportation network, transportation mode, and transportation insource/outsource, as well as identifying the stakeholders interested in the study. The third step of the proposed framework refers to the group decision making regarding the three components of the transportation strategy that have already been mentioned, while involving the stakeholders and taking into account the specificities of transported products. Many participatory techniques can be applied to involve the stakeholders in the decisional process, such as newsletters, reports, presentations, public hearings, interviews, questionnaires, surveys, workshops, participatory mapping, focus groups, newsletters, meetings, and informal discussions. The third step requires high input from stakeholders and their support for the decisions to be made. Deciding on the priority of these decisions, i.e., which decision will be made first depends on the stakeholders’ needs and preferences.
The group decision-making process involves several steps; the first one is analyzing the identified stakeholders to retain the most critical ones to be fully engaged in the decision process in order to satisfy their needs and expectations. The second step consists of identifying the problem associated with each component and the objectives that must be achieved in order to reach the final goals related to the transportation strategy. The third step involves the generation of the alternative options, the determination of the different criteria, and then a multicriteria group decision analysis (MCGDA) method is applied in order to determine the best option that meets the stated objectives, while taking into account the views of stakeholder groups. In fact, the reason behind the choice of the multicriteria group decision-making analysis method to be applied for deciding on transportation strategy is due to the presence of different stakeholders with multiple conflicting criteria involved in the decision-making process.
The fourth step of the proposed framework includes all necessary preparatory resources needed in order to bring the selected option to the point of operation; this stage can be supported by the participation of the stakeholders. Finally, an evaluation of the outputs of the implemented alternative is undertaken in order to determine whether the objectives have been met.
In the following section, we present a literature review regarding the key components of the proposed transportation strategy decision-making process, with the intent of creating a clear understanding of the problem at hand, as well as analyzing and defining the relevant criteria used in the literature in evaluating the problems associated with these components.
4. Application of the Proposed Framework: Case of the Moroccan Public Pharmaceutical Supply Chain
In this section, we apply our suggested approach to design a transportation strategy for the public pharmaceutical products supply chain in Morocco. In the first stage, we identify the context of the study, and we define the transportation strategy’s objectives that must be achieved. In the second stage, we analyze the actual transportation strategy to help create a clear understanding of what needs to be decided. After that, we identify all the stakeholders that may affect or be affected by the design of the Moroccan public pharmaceutical transportation strategy. Finally, we conduct a decision-making process regarding the design of the transportation network, while involving the relevant stakeholders and taking into account the specificities of pharmaceutical products, in order to design a successful transportation strategy.
4.1. Step 1: Context and Problem Definition
In recent years, Morocco launched a number of actions and strategies to enhance access to health services and improve health outcomes for the whole population. In this context, the Moroccan ministry of health had begun to establish a series of actions to improve the level of accessibility and availability of pharmaceutical products for Moroccan citizens.
With the generalization of basic health coverage in 2012, public hospitals must meet the increasingly important demand for care and must face a population that has become more demanding. To adapt to this strong demand, the annual budget allocated to the acquisition of pharmaceuticals has dramatically increased from 300 million dirhams in 2003 to more than 2 billion dirhams in 2018 [
85].
Faced with this situation, the current logistic circuit seems to be saturated and no longer adapted to the new challenges. For this reason, the Moroccan Ministry of Health expressed the need to develop an effective and efficient pharmaceutical supply chain through the proposition of strategic and tactical decisions with respect to the following six dimensions: (1) distribution networks, (2) facilities and installations, (3) inventory management, (4) transportation, (5) outsourcing (public–private partnership), and (6) the new technologies and information system [
81].
As can be seen from
Figure 5, the Moroccan public pharmaceutical supply chain is organized around several actors [
85]:
Supply division: Responsible for the consolidation of requirements of the different health institutions, the tenders’ launch, the reception, the storage, the distribution of pharmaceutical products, and the administrative management, as well as the supply monitoring.
Pharmaceuticals suppliers: 40 pharmaceutical laboratories and 20 suppliers of medical devices.
Central warehouses: which are four in number (Central Pharmacy in Casablanca, service management of pharmaceutical products in Berrechid, Beauséjour warehouse for thermolabile products and contraceptives, and Derb Ghallef Site for solid solutes).
Regional warehouses: They include four completed (Meknes, Agadir, Oujda and Al Hoceima) and four under construction (Tetouan, Marrakech, Guelmim, and Laayoune).
Public health institutions (customer zones): which are 159 in number, including 77 provincial and regional hospitals (PH) and (RH) and 82 provincial delegations (PD), which is in charge of supplying 2750 basic healthcare institutions.
Pharmaceutical products should be available in public health institutions at all times in sufficient quantities, delivered and administered safely. In this context, Morocco is making a major effort at increasing the budgets allocated to the acquisition of pharmaceutical products and developing techniques and measures providing health institutions the means to participate in defining their needs [
85]. Despite these efforts, several problems persist which are particularly related to the lack of responsiveness of the global chain, the lack of traceability of the logistic circuit of pharmaceutical products, which increased the risk of damage, and the unavailability of pharmaceuticals, which seriously damage the quality of care and causes patient dissatisfaction.
To address these problems, different decisions should be made in relation to the different flows of goods between suppliers and customers including facility location, production, inventory, and transportation [
1,
63].
Transportation is one of the major supply-chain drivers, as it is responsible for linking the whole supply chain from suppliers to customers. In this sense, we are going to design an appropriate transportation strategy that improves the efficiency and responsiveness of the Moroccan public pharmaceutical supply chain.
4.2. Step2: Transportation Strategy Analysis
Transportation of pharmaceutical products is the most important part in a logistics chain because the products being transported are for human consumption. Therefore, it is necessary to develop an appropriate transportation system to ensure that the medicines arrive to consumer in perfect conditions.
In the Moroccan public sector, the deliveries of pharmaceuticals are made by the supply division of the Ministry of Health in a planned way with typically four deliveries per year with an annual volume of 25,000 tons of products.
The products are transported by using small trucks or small vans from suppliers to the storage sites of the Moroccan Ministry of Health, which are divided into central and regional warehouses. The central warehouse usually has copious storage capacity, and it is in charge in delivering the received products, either directly or via regional warehouses, to the customer zones, including provincial and regional hospitals (PH and RH) and provincial delegations (PD) by using smaller vans and cars.
The distance for the transportation of pharmaceutical products is about 700,000 km yearly. The supply division is responsible for delivering pharmaceuticals to provincial and hospital pharmacies through contractual transportation companies. Meanwhile, basic healthcare facilities are delivered by the delegations’ own transportation means. The trucks used for transporting products have different capacities depending on the demand to be delivered (19 tons, 25 tons, and 7 tons).
The Moroccan pharmaceutical-products transportation system knows the intervention of a multiplicity of stakeholders with different levels of competences and interests. As depicted in
Table 4, we elaborated on a list of the stakeholders interested in designing the pharmaceuticals transportation system, according to information from our meetings with some professionals of the Moroccan Ministry of Health, our visits to some pharmaceuticals warehouses, such as “the management of pharmaceutical products service in Berrechid”, and based on the literature review about the healthcare and transportation sectors.
4.3. Step 3: Group Decision-Making Process
Designing the appropriate pharmaceuticals transportation strategy involves various groups of stakeholders with different interests and wants, which makes achieving their satisfaction a difficult objective to realize. In this sense, it is of great importance to prioritize them to retain the most critical ones to be fully engaged in the design process in order to satisfy their needs and expectations.
4.3.1. Analyze the Identified Stakeholders
We have used the DELPHI method [
86] to complete the established list of stakeholders and to prioritize them according to their degree of “having an influence on” and “being impacted by” the design of the transportation strategy of the pharmaceutical products in the Moroccan public sector. A key advantage of the Delphi method is its openness to a diverse set of expert opinions without having to bring everyone together for a physical meeting [
87]. Also, it is considered to be an effective method for gaining judgments on complex matters where precise information is unavailable [
87]. In addition, the DELPHI method has been widely used to determine consensus in a number of important need areas, especially in the healthcare field [
88,
89,
90].
We have been inspired by the work of [
90] in applying the following steps of the Delphi method:
Identification of panel of experts: They should have relevant knowledge and experience in their respective fields. In this manner, 16 people were identified and contacted either directly or via email. Through feedback, 10 of them expressed their agreement to be part of the panel as shown in
Table 5.
Design the questionnaire: Firstly, we demanded to each expert to consult the established list of stakeholders and to add others that may be considered pertinent. Then, we outlined some dimensions regarding the transportation of pharmaceuticals to be considered in the questionnaire, so the experts could have a common understanding of the study context (
Table 6). After that, we demanded that each expert assign two scores to each stakeholder regarding their “having an influence on” and “being impacted by” the different dimensions concerning the design of the transportation strategy of pharmaceuticals, using a scale from 1 to 5: very low (1), low (2), medium (3), high (4), and very high (5).
Consultation of the experts and analysis of results: The questionnaire has been administered to each expert by email or via direct contact. Then, the questionnaires are returned to be analyzed, aggregated, and shared with the different experts. Several rounds of questionnaires can be sent out to the group of experts until arriving at a group consensus. The degree of consensus among experts is assessed using Kendall’s W coefficient of concordance. This coefficient measures the extent to which the experts agree on their rankings, it ranges between 0 (Perfect disagreement) and 1 (perfect agreement). For a value of W less than 0.7, the questionnaire should be sent back to experts [
91]. All experts found that the established list containing all the stakeholders that should be involved in designing the appropriate transportation strategy for the Moroccan public pharmaceutical sector.
To analyze the experts’ answers, we started by calculating the sum of the scores assigned to each stakeholder regarding their “having an influence on” and “being impacted by” the different mentioned dimensions. Then, the completed experts’ responses were analyzed using IBM SPSS Statistics software (IBM, Armonk, NY, USA). The first Delphi round indicated values of W less than 0.7. Hence, the questionnaire was sent back a second and third time to each expert for new responses, accompanied by his or her own rating in the previous rounds and the consolidated result of the panel’s responses. The third round showed an increase of W, which exceeded 0.7, indicating a better degree of consensus (
Table 7).
For a better understanding of this prioritization, we have put the stakeholders in the influence/impact matrix proposed by [
92] (
Figure 6).
As can be seen from
Figure 6, all the identified stakeholders are both influencing and influenced by designing an appropriate transportation strategy for the Moroccan pharmaceutical public sector. Nevertheless, six stakeholders have the highest score: patients (S11), Ministry of Health (S1), public healthcare facilities and healthcare personal (S7), Ministry of Transport (S3), healthcare industry (S8), and local authorities (S5). Those stakeholders are the most critical ones with regard to the design of the appropriate pharmaceuticals transportation strategy, and they need to be fully engaged in the decision-making process in order to satisfy their needs and expectations. However, the other stakeholders should be adequately informed in order to keep their satisfaction and to maintain their engagement.
However, it should be noted that the identified stakeholders and their obtained classification can be updated at regular intervals over time, according to the happened changes in the environment.
Moreover, designing the appropriate pharmaceuticals transportation strategy requires decision making regarding different components: designing the appropriate transportation network, choosing the suitable transportation mode, and deciding which part of the transportation process will be outsourced and which one will be insourced, while involving the relevant stakeholders and taking into account the specificities of the pharmaceutical products. In this paper, we are interested in designing the transportation network.
In the following section, we conduct a decision-making process to choose the most appropriate transportation-network design option for the Moroccan public pharmaceutical supply chain while involving the main stakeholders and taking into account the specificities of pharmaceutical products.
4.3.2. Choosing the Appropriate Transportation Network
We have proposed, in a previous work [
63], a framework for designing the appropriate transportation network for a given supply chain, and we have illustrated the application of this framework in choosing the most appropriate transportation-network design option for the Moroccan public pharmaceutical supply chain.
However, we realized that the analysis of the transportation system should involve many social groups and different aspects. Accordingly, we have decided to engage the identified key stakeholders in choosing the appropriate transportation-network design option for the public pharmaceutical supply chain in Morocco.
Four transportation-network design options were proposed in [
63]:
- ✓
(TN1): Products shipping via central/regional warehouses;
- ✓
(TN2): Products shipping via central/regional warehouses by using milk run from suppliers to central warehouses;
- ✓
(TN3): Products shipping via central/regional warehouses by using milk run from regional warehouses to a supply chain’s customers;
- ✓
(TN4): Products shipping via central/regional warehouses by using milk run from suppliers to central warehouses and from regional warehouses to a supply chain’s customers.
The choice of the appropriate transportation-network design option is based on a set of criteria (Cj). Based on the previous list of criteria determined according to the literature (
Table 3), six criteria that could glue to our context have been selected.
Criteria to minimize:
- -
Delivery time: the actual time between placing an order and receiving the delivered product.
- -
Number of trucks: the use of milk run reduces the number of trucks utilized for shipping pharmaceutical products.
- -
Transportation cost: consolidating shipments lowers transportation cost.
- -
Information system cost: the use of milk runs increases the cost of information system because it requires a significant degree of coordination.
- -
Criteria to maximize:
- -
Regulatory criteria: Transporting pharmaceutical products should be carried out according to requirements of the drugs act in order to avoid the risk of impacting the safety, quality, and effectiveness of pharmaceuticals.
- -
Flexibility: Ability to respond to unexpected events in order to satisfy the customer’s specific needs.
Six key stakeholders were contacted representing the six main interest stakeholder groups which have already been mentioned. Through feedback, only five stakeholders expressed their agreement to participate in the decision-making process: (1) Ministry of Health (S1), (2) Ministry of Transport (S3), (3) public healthcare facilities and healthcare personnel (S7), (4) healthcare industry (S8), and (5) patients (S11). Stakeholders were individually contacted and approached directly or through emails explaining the objective of the study with a detailed description of the four different alternatives in terms of strengths and weaknesses. Then, they were asked to confirm the established list of criteria. Nevertheless, deciding io the appropriate transportation network while engaging the key stakeholders and taking into account the different criteria needs to be tackled with a multicriteria decision-making approach.
Many MCDA methods exist, but the analytic hierarchy process (AHP), proposed by [
93], is used in this paper because of its simplicity, its flexibility, and its ability to deal with different types of information features [
94]. Furthermore, throughout this method, the hierarchy is revealed after the breakdown of the problem, which enables understanding and defining the process itself [
95]. The AHP method has been widely used to support decision making in several and different fields, especially in transportation issues [
7,
12,
96,
97].
In addition, as different persons affect the decision-making process, the AHP method has been adapted to be applied in group decision making. Hence, it is considered a useful method to support stakeholder engagement in making appropriate decisions [
14,
98].
There are different ways to combine the preferences of the decision makers into a consensus rating [
12]: according to the level of aggregation (from judgments or from priorities) and the type of aggregation (mathematical or based on consensus vote). The consensus vote is used when stakeholders reach an agreement on the values of the matrices or on the priority vectors; otherwise, the mathematical aggregation is adopted. There are two synthesizing methods that provide the same results in case of acceptable consistency of the pairwise comparison matrices [
12]: the weighted geometric mean method (WGMM) or weighted arithmetic mean method (WAMM). In the first method, the geometric means of individual judgements are used as elements in the pairwise comparison matrices and then priorities are computed. Meanwhile, in the second method, priorities are computed and then aggregated using the weighted arithmetic mean method [
12].
In the following section, we applied the different steps of the AHP method [
93] to select the most appropriate transportation network for the Moroccan public pharmaceutical supply chain.
First, a hierarchical structure of the problem was modeled (
Figure 7). Starting with the top level, the global goal is to choose the most appropriate transportation network. The second level identifies the main stakeholders that are involved in the decision making. In the third level, we present the evaluation criteria. Finally in the last level, the different transportation-network alternatives (TNi) are presented, from which we will be able to choose the best transportation-network option. After a brief reminder of the AHP methodology to the different key stakeholders, they were given the opportunity to revise the hierarchy model and to validate it.
Then, the stakeholders’ weight was evaluated from the stakeholders themselves (self-assessed weights) through a questionnaire. The judgements were justified by the analysis of the results of DELPHI method (
Table 8).
After that, each of the stakeholders was asked to make pairwise comparisons for the different alternatives against each criterion and for the different criteria while verifying the consistency. Then, an aggregation of the priority vectors of different alternatives, while taking into account the criteria weights, was performed in order to obtain the ranking of alternatives according to each stakeholder (
Figure 8b).
As can be seen from
Figure 8a, the regulatory criteria are considered to be the most important criterion, followed by transportation cost, delivery time, number of trucks, flexibility, and information system cost. These results are clearly in line with the preferences that key stakeholders expressed in questionnaires. Regarding the priority vector of alternatives as shown in
Figure 8b, the fourth transportation-network alternative (TN4) shows the highest priority for four stakeholders (S1, S7, S8, and S11), while the first transportation-network alternative (TN1) is the first ranked for the Ministry of Transport (S3).
In the following section, aggregation of individual priorities has been performed, while applying the weighted arithmetic mean method to derive a collective decision as an output of the AHP methodology (
Figure 9). A consultation process with the five stakeholders was structured through conducting interviews over the telephone and face-to-face meetings, in order to show them the final results that confirm that the TN4 with the highest score of 0.46 is the most appropriate transportation network for the current Moroccan public pharmaceutical distribution network. We have also discussed the benefits of the chosen option which are decreasing transportation cost through consolidation and reducing the number of trucks utilized for shipping pharmaceuticals through the use of milk run. Also, using milk run reduces the inventory-storage level, preventing the pharmaceuticals from being stored for a long time, which can impact their safety, quality, and effectiveness.
5. Discussion
Transportation is at the heart of supply-chain operations, as it is the responsible for ensuring the movement of products from supply sites to customers. Deciding on the appropriate transportation strategy requires the participation of multiple stakeholders with different interests and expectations. The main objective of this paper was to propose a framework for designing an appropriate transportation strategy for a supply chain from a multistakeholder perspective. This research work was born from the need of the Moroccan Ministry of Health in improving the efficiency and the responsiveness of the pharmaceutical public supply chain in order to satisfy the increasing demand of pharmaceuticals. We have applied the suggested framework for deciding on the appropriate strategy for transporting pharmaceuticals in the Moroccan public sector.
First, an analysis of the current pharmaceuticals supply chain was carried out in order to have a clear understanding of the actual situation, to determine the multiple daunting challenges faced by the current supply system, and to define the objectives that must be achieved to meet the Ministry of Health‘s expectations. Then, we analyzed the current transportation strategy regarding its three components: transportation network, transportation mode, and transportation outsource/insource. We established a list of the different stakeholders interested in the design of the pharmaceuticals transportation strategy for the Moroccan public sector. The identification of stakeholders was done based on the literature review conducted on previous studies on healthcare and transportation sectors, and also, through the analysis of some conducted interviews and work meetings with the professionals of the Ministry of Health. These stakeholders were prioritized, while applying the DELPHI method, according to their degree of “having an influence on” and “being impacted by” the design of the transportation strategy of the pharmaceutical products in the Moroccan public sector. The findings have allowed the identification of six key stakeholders to be fully engaged in transportation strategy decision-making process:
Patients (S11): They are at the core of the health system. The World Health Organization emphasized to put the patients at the center of the healthcare system by meeting their needs and expectation [
99]. The patients are the most impacted by the design of the appropriate pharmaceuticals transportation strategy by providing them high-quality pharmaceuticals whenever and wherever they are needed.
Ministry of health (S1): It plays a crucial role in the design of the pharmaceuticals transportation strategy through strengthening the Moroccan’s healthcare system and having the overall responsibility for the management and development of that system.
Public healthcare facilities (S7): They are the primary means of the healthcare delivery to patients. They play a potential role in the design of the pharmaceuticals transportation strategy through their location in the distribution network, their respect of patient’s preferences, and their ability to ensure the availability of pharmaceutical products to patients.
Ministry of Transport (S3): It plays an important role in the design of the pharmaceutical transportation strategy, as it is responsible for transportation within the Moroccan’s country including overseeing road safety and developing government transportation policies.
Healthcare industry (S8): It plays a key role in the healthcare system as it is the responsible of the production and the distribution of healthcare products, especially the pharmaceuticals, to the different healthcare institutions.
Local authorities (S5): They represent a key participant in the implementation of national healthcare strategies.
We contacted six stakeholders representing the identified key stakeholder groups for participating in the transportation strategy decision-making process. Through feedback, only five stakeholders expressed their agreement to participate. (1) Ministry of Health (S1), (2) Ministry of Transport (S3), (3) public healthcare facilities and healthcare personnel (S7), (4) healthcare industry (S8), and (5) patients (S11).
After that, we applied the AHP Group method to choose the appropriate transportation-network design option for the Moroccan public pharmaceutical supply chain while involving the identified key stakeholders into. The results showed that applying the milk-run option from suppliers to central warehouse, as well as from regional warehouses to customer zones, is the most suitable transportation-network option for shipping the pharmaceutical products in the Moroccan‘s current public distribution network.
The findings of this research work raise some interesting research questions and create promising perspectives for future work. We summarize below a list of some potential research venues:
Deciding on the others transportation strategy’s components while involving the relevant stakeholders into choosing the appropriate transportation mode, as well as deciding which part of the transportation process will be outsourced and which one will be insourced.
The proposed transportation strategy decision-making process was conducted while engaging five key stakeholders that represent five key stakeholder groups: namely, (1) Ministry of Health, (2) Ministry of Transport, (3) public healthcare facilities and healthcare personnel, (4) healthcare industry, and (5) patients. However, in order to improve the quality of the decisions to be made, we look for involving others performing persons representing the key stakeholder groups.
Having a clear insight on the stakeholders involved in the decision-making process and the interactions among them is helpful in guiding an effective participation process aimed at consensus building among stakeholders. In this sense, we propose, for our future work, to use a modeling approach based on participatory modeling methods such as: the social network analysis (SNA), discrete choice models (DCM), and agent-based models (ABM).
Improving the proposed framework to be adapted for designing a smart transportation strategy through the employment of the digital and telecommunication technologies like information and communications technology (ICT) and the Internet of things (IoTs). The design of such transportation system will have numerous benefits including improving the life quality of the entire population and maximizing the sustainability and environmental conservation [
100].
Another issue that deserved investigating is to use other multi-criteria decision analysis (MCDA) methods adapted to be applied in the group decision-making context participation to evaluate and analyze the performance of the decisions to be made.
6. Conclusions
In this paper, we presented a framework for designing an appropriate transportation strategy for a supply chain while involving the concerned stakeholders and taking into account the specificities of the transported products.
This framework was applied to a real case study of the Moroccan public pharmaceutical supply chain. First, we defined the transportation strategy decision-making context and the objectives that must be achieved. Second, we analyzed the current transportation strategy regarding their three components: transportation network, transportation mode, and transportation insource/outsource. Then, we identified the stakeholders interested in designing the pharmaceuticals transportation system. Finally, in the third step, we conducted a group decision-making process regarding the transportation-network design component. In this sense, the identified stakeholders were first analyzed and hierarchized while employing the DELPHI method to determine the key of them. After that, we have applied the Group AHP MCDA method for selecting the appropriate transportation-network design option while involving the identified key stakeholders into. The results showed that shipping products via central/regional warehouses with using milk run from suppliers to central warehouses and from regional warehouses to a supply chain’s customers is the most suitable transportation-network option for shipping the pharmaceuticals in the Moroccan’s public pharmaceutical supply chain.
Future work will deal with choosing the appropriate transportation mode, as well as deciding which part of the transportation process will be outsourced and which one will be insourced, while involving the relevant stakeholders.